Effectiveness and safety of aripiprazole oral solution in the acute treatment of schizophrenia in Chinese patients
Abstract Background This study investigates the effectiveness and safety of aripiprazole oral solution in Chinese patients with schizophrenia. Methods This was a multicenter, single-arm phase IV study involving 134 patients in China in the acute stage of schizophrenia from May 2021 to July 2022. The...
Saved in:
Main Authors: | Zhen Mao, Fang Dong, Anning Li, Feng Li, Junhong Zhu, Xiangdong Du, Gang Wu, Huaili Deng, Xueqin Yu, Jintong Liu, Shiping Xie, Xiaowei Tang, Gang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-024-06455-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia
by: Sanya Sharma, et al.
Published: (2023-10-01) -
Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatment
by: Yin Cao, et al.
Published: (2024-12-01) -
Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas
by: Edward Mignone, et al.
Published: (2025-01-01) -
Influence of ABCB1 polymorphisms on aripiprazole and dehydroaripiprazole plasma concentrations
by: Francisco José Toja-Camba, et al.
Published: (2025-01-01) -
The emotional facial recognition performance of Chinese patients with schizophrenia: An event-related potentials study
by: Yangjun Zhang, et al.
Published: (2023-03-01)